 Home > Biochemistry News > Biotechnology News > Treat diabetes! CRISPR-edited cell replacement therapy enters the clinic

Treat diabetes! CRISPR-edited cell replacement therapy enters the clinic

 Last Update: 2021-12-02
 Source: Internet
 Author: User

Tags

ketosis prone diabetes

cell cytosol

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 16, 2021, ViaCyte and CRISPR Therapeutics jointly announced that Health Canada has approved a clinical trial application (CTA) for CRISPR gene-edited stem cell-derived therapy VCTX210 for the treatment of type 1 diabetes (T1D)

The islet cells derived from the differentiation and expansion of stem cells in vitro will cause immune rejection, which will cause the body’s immune system to attack these cells and reduce the durability of the therapy

PEC Direct (VC-02), developed by ViaCyte, encapsulates the islet progenitor cells derived from stem cells in a "pocket" that can be implanted under the skin of the patient.

VCTX210 is derived from ViaCyte's pluripotent stem cell line CyT49

Reference materials:

[1] CRISPR Therapeutics and ViaCyte, Inc.

https://crisprtx.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.